Hertraz 150 mg Injection
Molecule: Trastuzumab
Strength: 150 mg
Quantity: 1 Vial
Form: Injection
Packaging Type: Single-use vial
Manufacturer/Marketed By: Mylan
Country of Origin: India
Request Pricing & Availability
Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.
Similar Products
| Product | Manufacturer / Marketed By | Price |
|---|---|---|
Herceptin 150 mg Vial
|
Roche | Ask for Price |
Herti 150 mg Injection
|
Hetero Healthcare | Ask for Price |
Description
Indications and Usage
How it Works
Dosage & Administration
Side Effects
Warning and Precaution
Related Products
-
Zyceva 100 mg Tablet
ErlotinibPrice on request
Request pricing -
Imatikast 400 mg Tablet
ImatinibPrice on request
Request pricing -
Pomalid 1 Mg Capsule
PomalidomidePrice on request
Request pricing -
Pomalid 2 Mg Capsule
PomalidomidePrice on request
Request pricing -
Pazonat 200 mg Tablet
PazopanibPrice on request
Request pricing -
CA Atra 10 mg Softgel Capsule
TretinoinPrice on request
Request pricing -
Sutinat 25 mg Capsule
SunitinibPrice on request
Request pricing -
Sutinat 12.5 mg Capsule
SunitinibPrice on request
Request pricing -
Spnib 100 mg Tablet
DasatinibPrice on request
Request pricing -
Azatend 100 mg Injection
AzacitidinePrice on request
Request pricing -
Tegonat 15 mg Capsule
TegafurPrice on request
Request pricing -
Bdenza 40 mg Capsule
EnzalutamidePrice on request
Request pricing
Related Reading
-
FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026. Breast cancer treatment continues to evolve
-
First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026. n Metastatic breast cancer (mBC) remains
-
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue
-
Healing After Radiation: Is a Nipple-Sparing Mastectomy Possible?
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 20, 2026. n For many years, patients who
-
Oral SERDs Explained: The New Hormone Therapy Option After Endocrine Resistance in HR+ Breast Cancer
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 25, 2026. n Hormone receptor-positive, HER2-negative breast cancer
-
Does Ribociclib Still Help After 3 Years? The NATALEE Trial’s 4-Year Follow-Up Answers
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026. n For patients with hormone receptor–positive,
Shipping & Delivery
- Ships from
- India, worldwide delivery
- Order processing
- 1–3 business days after checks
- Transit time
- 5–7 business days by express courier
- Tracking
- Tracking number sent by email or SMS
- Packaging
- Discreet, tamper-evident, cold-chain available
- Duties & taxes
- Payable by the recipient on import